Adult Glioblastoma — Trials

Adult Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

139 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 22
Recruiting: 13
Ph III recruiting: 3
Growth YoY: —
Industry share: 27%
Top sponsor: Northwell Health
Termination share: 41.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 51–67 of 67 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00445588	Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme	completed	Phase 2	56	National Cancer Institute (NCI)NIH	1	Apr 27, 2016	clinicaltrials
NCT00499473	Sunitinib in Treating Patients With Recurrent Malignant Gliomas	completed	Phase 2	31	National Cancer Institute (NCI)NIH	1	Feb 29, 2016	clinicaltrials